NASDAQ:ENTA | Free Cash Flow | ENANTA PHARMACEUTICALS INC

Free cash flow is operating cash flow less capital expenditure. FCF / net income requires positive matching-period earnings.

Available history
2011-09-30 to 2025-12-31
Data captured

Historical Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-12-31-$11.7M$143,000.00-$11.84M
2025-09-30-$6.49M$1.46M-$7.95M
2024-12-31-$16.8M$8.75M-$25.55M
2024-09-30-$10.4M$8.95M-$19.35M
2023-12-31-$24.99M$787,000.00-$25.78M
2023-09-30-$21.6M$1.37M-$22.97M
2022-12-31-$35.64M$3.16M-$38.8M
2022-09-30-$15.53M$1.44M-$16.97M
2021-12-31-$13.27M$363,000.00-$13.63M
2021-09-30-$21.02M$33,000.00-$21.05M
2020-12-31-$14.89M$188,000.00-$15.08M
2020-09-30-$15.46M$330,000.00-$15.79M
2019-12-31$12.36M$488,000.00$11.88M88.34%
2019-09-30$8.55M$296,000.00$8.25M89.75%
2018-12-31$30.25M$384,000.00$29.87M114.84%
2018-09-30$28.34M$623,000.00$27.72M101.09%
2017-12-31$4.41M$504,000.00$3.91M33.40%
2017-09-30$57.31M$234,000.00$57.07M156.33%
2016-12-31$3.15M$953,000.00$2.19M
2016-09-30-$2.13M$415,000.00-$2.54M
2015-12-31$29.99M$2.2M$27.8M106.14%
2015-09-30-$2.38M$1.58M-$3.96M-68.05%
2014-12-31-$5.61M$256,000.00-$5.87M-13.96%
2014-09-30-$4.93M$485,000.00-$5.42M
2013-12-31-$5.87M$24,000.00-$5.9M
2013-09-30-$2.5M$202,000.00-$2.71M
2012-12-31$9.05M$11,000.00$9.03M41.14%
2012-09-30-$1.7M$111,000.00-$1.81M

Annual Free Cash Flow

DateOperating cash flowCapital expenditureFree cash flowFCF / net income
2025-09-30-$19.27M$12.9M-$32.17M
2024-09-30-$78.76M$17.95M-$96.71M
2023-09-30-$103.15M$9.06M-$112.21M
2022-09-30-$84.78M$2.13M-$86.91M
2021-09-30-$70M$750,000.00-$70.75M
2020-09-30$7.09M$1.45M$5.64M
2019-09-30$71.42M$5.42M$66M142.30%
2018-09-30$29.22M$2.98M$26.24M36.47%
2017-09-30$52.65M$2.51M$50.15M283.16%
2016-09-30$35.81M$4.74M$31.07M143.41%
2015-09-30$76.67M$2.34M$74.34M94.11%
2014-09-30$20.18M$1.03M$19.15M55.61%
2013-09-30$10.65M$606,000.00$10.05M104.36%
2012-09-30$22.62M$252,000.00$22.37M104.54%
2011-09-30$24.02M$445,000.00$23.57M101.13%